Intellia Therapeutics, Inc. (NTLA)

$16.54 -5.49% $-0.96 Healthcare

Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemophilia A and hemophilia B, hyperoxaluria Type 1, and alpha-1 antitrypsin deficiency. Its ex vivo pipeline includes NTLA-5001 for the treatment of acute myeloid leukemia; and proprietary programs focused on developing engineered cell therapies to treat various oncological and autoimmune disorders. In addition, it offers tools comprising of Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. Intellia Therapeutics, Inc. has license and collaboration agreements with Novartis Institutes for BioMedical Research, Inc. to engineer hematopoietic stem cells for the treatment of sickle cell disease; Regeneron Pharmaceuticals, Inc. to co-develop potential products for the treatment of hemophilia A and hemophilia B; Ospedale San Raffaele; and a strategic collaboration with SparingVision SAS to develop novel genomic medicines utilizing CRISPR/Cas9 technology for the treatment of ocular diseases. The company was formerly known as AZRN, Inc. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

$1.68B

Dr. John M. Leonard M.D.

485.00

Cambridge, MA

May 06, 2016

-3.03

$-5.45

1.14

6.73

-1,212.19%

-3.38

0.85

1.84

41.37

6.73

-44.51%

-51.97%

Similar stocks (7)

Beam Therapeutics Inc.

BEAM

$27.94 -7.94%
Neutral

Sana Biotechnology, Inc.

SANA

$2.82 -2.25%
Downtrend

Prime Medicine, Inc.

PRME

$4.26 -2.85%
Downtrend

Ginkgo Bioworks Holdings, Inc.

DNA

$8.39 -4.22%
Downtrend

Fate Therapeutics, Inc.

FATE

$2.38 -7.03%
Downtrend

Editas Medicine, Inc.

EDIT

$3.07 -6.97%
Downtrend

Caribou Biosciences, Inc.

CRBU

$2.34 -15.95%
Downtrend

ETF Exposure (34)

Global X Genomics & Biotechnology ETF

GNOM

3.23%

$10.57 -2.94%
Downtrend

ARK Innovation ETF

ARKK

2.19%

$56.81 -1.80%
Uptrend

Listed Funds Trust - Horizon Kinetics Medical ETF

MEDX

1.44%

$29.40 -0.54%
Downtrend

Franklin Genomic Advancements ETF

HELX

0.52%

$31.23 -0.61%
Downtrend

iShares Genomics Immunology and Healthcare ETF

IDNA

0.39572%

$24.71 -3.19%
Uptrend

Direxion Daily S&P Biotech Bull 3X Shares

LABU

0.3934400066%

$134.40 -6.91%
Uptrend

Invesco Nasdaq Biotechnology ETF

IBBQ

0.173%

$23.77 -2.42%
Uptrend

iShares Biotechnology ETF

IBB

0.16594%

$144.36 -2.27%
Uptrend

iShares Russell 2000 Value ETF

IWN

0.11745%

$177.58 -1.76%
Uptrend

iShares Morningstar Small-Cap Growth ETF

ISCG

0.06471%

$52.74 -1.35%
Uptrend

iShares Russell 2000 ETF

IWM

0.05791%

$237.36 -1.79%
Uptrend

Schwab U.S. Small-Cap ETF

SCHA

0.0567510925%

$27.60 -1.55%
Uptrend

SPDR S&P Kensho New Economies Composite ETF

KOMP

0.053257%

$53.35 -1.98%
Uptrend

ProShares Ultra Nasdaq Biotechnology

BIB

0.05076037368957527%

$62.76 -5.40%
Uptrend

iShares ESG Aware MSCI USA Small-Cap ETF

ESML

0.04297%

$44.63 -1.35%
Uptrend

Dimensional U.S. Small Cap ETF

DFAS

0.04132589%

$69.37 -1.28%
Uptrend

Vanguard Small Cap Index Fund

NAESX

0.04%

$122.72 1.19%
Uptrend

iShares Morningstar Small-Cap ETF

ISCB

0.03263%

$62.50 -1.39%
Uptrend

Invesco FTSE RAFI US 1500 Small-Mid ETF

PRFZ

0.031%

$44.25 -1.54%
Uptrend

Fidelity MSCI Health Care Index ETF

FHLC

0.02738176%

$70.21 -1.45%
Neutral

ALPS Medical Breakthroughs ETF

SBIO

0.0103%

$41.00 -3.37%
Uptrend

ProShares Hedge Replication ETF

HDG

0.009011222118665153%

$50.24 -0.58%
Uptrend

Dimensional U.S. Targeted Value ETF

DFAT

0.00419985%

$59.32 -1.23%
Uptrend

Schwab U.S. Broad Market ETF

SCHB

0.0039834045%

$23.18 -0.56%
Uptrend

iShares Russell 3000 ETF

IWV

0.00261%

$342.01 -0.45%
Uptrend

Dimensional U.S. Equity ETF

DFUS

0.0022004399999999997%

$65.17 -0.40%
Uptrend

Dimensional U.S. Core Equity 2 ETF

DFAC

0.00203595%

$35.93 -0.53%
Uptrend

Dimensional US Core Equity Market ETF

DFAU

7.733200000000001e-4%

$41.57 -0.38%
Uptrend

Vanguard ESG U.S. Stock ETF

ESGV

0%

$106.49 -0.25%
Uptrend

Goldman Sachs Innovate Equity ETF

GINN

0%

$63.64 -0.68%
Uptrend

Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF

GSSC

0%

$74.69 -1.67%
Uptrend

iShares Core S&P Total U.S. Stock Market ETF

ITOT

0%

$131.55 -0.45%
Uptrend

John Hancock Multifactor Large Cap ETF

JHML

0%

$72.10 -0.51%
Uptrend

Fidelity Nasdaq Composite Index ETF

ONEQ

0%

$75.82 -0.41%
Uptrend